Immunologic Response to the Dual Murine Anti‐Id Vaccine Melimmune‐1 and Melimmune‐2 in Patients with High‐Risk Melanoma Without Evidence of Systemic Disease
暂无分享,去创建一个
J. Murray | A. Solinger | A. Lobuglio | M. Saleh | M. Pride | D. Lalisan | M. Mayo | M. Mayo | Michael W. Pride | Alan Solinger | Albert F. LoBuglio | J. L. Murray | Matthew S. Mayo | M. Saleh